These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7878046)

  • 1. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I IL-1 receptor: ligand specific confirmation differences and the role of glycosylation in ligand binding.
    Einstein R; Jackson JR; D'Alessio K; Lillquist JS; Sathe G; Porter T; Young PR
    Cytokine; 1996 Mar; 8(3):206-13. PubMed ID: 8833035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
    Mehraban F; Kasturi S
    Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a novel soluble receptor for interleukin 1.
    Symons JA; Eastgate JA; Duff GW
    J Exp Med; 1991 Nov; 174(5):1251-4. PubMed ID: 1834761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.
    Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE
    Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra).
    Brown EA; Dare HA; Marsh CB; Wewers MD
    Cytokine; 1996 Nov; 8(11):828-36. PubMed ID: 9047079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
    Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
    J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
    Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
    Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.
    Giri JG; Wells J; Dower SK; McCall CE; Guzman RN; Slack J; Bird TA; Shanebeck K; Grabstein KH; Sims JE
    J Immunol; 1994 Dec; 153(12):5802-9. PubMed ID: 7989776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo.
    Daun JM; Ball RW; Burger HR; Cannon JG
    J Leukoc Biol; 1999 Jun; 65(6):863-6. PubMed ID: 10380911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1beta and of the type I and type II IL-1 receptors.
    Kol S; Ruutiainen-Altman K; Scherzer WJ; Ben-Shlomo I; Ando M; Rohan RM; Adashi EY
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):115-28. PubMed ID: 10375024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils.
    Jablonska E; Izycka A; Jablonska J; Wawrusiewicz N; Piecuch J
    Immunol Invest; 2001 Aug; 30(3):221-9. PubMed ID: 11570642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome.
    Cannon JG; Angel JB; Abad LW; Vannier E; Mileno MD; Fagioli L; Wolff SM; Komaroff AL
    J Clin Immunol; 1997 May; 17(3):253-61. PubMed ID: 9168406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.
    Re F; Muzio M; De Rossi M; Polentarutti N; Giri JG; Mantovani A; Colotta F
    J Exp Med; 1994 Feb; 179(2):739-43. PubMed ID: 8294881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.